Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of Alex Aildenafil Citrate Tablets in male patients with erectile dysfunction
ChiCTR2300070771Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aildenafil in erectile dysfunction (ED), sponsored by Peking University First Hospital. Primary endpoints: International Index of Erectile Function-5 (IIEF-5), Global Assessment Question (GAQ) and 1 more. Started Nov 2022; status: recruiting.
02
Drugs
aildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on ChiCTR2300070771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070771.